Two Seas Capital LP, the largest active shareholder of Core Scientific, Inc., announced Thursday its opposition to the ...

Two Seas Capital LP ("Two Seas" or "we"), an alternative investment management firm and the largest active shareholder of ...

Two Seas Capital opposes Core Scientific's all-stock acquisition by CoreWeave, citing undervaluation and risk.

Two Seas Capital moves to block CoreWeave’s $9B all-stock deal for Core Scientific, citing low valuation and high risk.

Core Scientific snapped a seven-day winning streak on Wednesday, shedding 8.34 percent to close at $13.85 apiece as investors ...